Literature DB >> 6411389

Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.

G Schaison, B Couzinet, N Moatti, B Pertuiset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6411389     DOI： 10.1111/j.1365-2265.1983.tb00591.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.

Authors:  D Giannella-Neto; B L Wajchenberg; B B Mendonça; S F Almeida; M Macchione; E M Spencer
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

2.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

3.  The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.

Authors:  M Giusti; A Lomeo; M Monachesi; G Mazzocchi; R Attanasio; P Sessarego; D Mignone; P Del Monte; G Giordano
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

Review 4.  Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly.

Authors:  Laure Cazabat; Jean-Claude Souberbielle; Philippe Chanson
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.

Authors:  G Plewe; J Schrezenmeir; G Nölken; U Krause; J Beyer; H Kasper; E del Pozo
Journal:  Klin Wochenschr       Date:  1986-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.